Long-term survival and prognostic study in acute promyelocytic leukemia treated with alRnrns-retinoic acid, chemotherapy, and As2O3: An experience of 120 patients at a single institution

International Journal of Hematology

Volumn 70, Issue 4, 1999, Pages 248-260

  Hu, Jiong ^a  

^a Shanghai Institute of Hematology   (China)

Author keywords

Acute promyelocytic leukemia; All trans retinoic acid; Arsenic trioxide; Chemotherapy

Indexed keywords

ANTINEOPLASTIC AGENT; ARSENIC TRIOXIDE; ONCOPROTEIN; ORGANOARSENIC DERIVATIVE; OXIDE; PROMYELOCYTIC LEUKEMIA RETINOIC ACID RECEPTOR ALPHA FUSION ONCOPROTEIN; PROMYELOCYTIC LEUKEMIA-RETINOIC ACID RECEPTOR ALPHA FUSION ONCOPROTEIN; RETINOIC ACID; TUMOR PROTEIN;

ADOLESCENT; ADULT; AGED; ARTICLE; CHILD; CLINICAL TRIAL; FEMALE; FOLLOW UP; HUMAN; MALE; MIDDLE AGED; PROGNOSIS; PROMYELOCYTIC LEUKEMIA; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SURVIVAL RATE;

ADOLESCENT; ADULT; AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; ARSENICALS; CHILD; FEMALE; FOLLOW-UP STUDIES; HUMANS; LEUKEMIA, PROMYELOCYTIC, ACUTE; MALE; MIDDLE AGED; NEOPLASM PROTEINS; ONCOGENE PROTEINS, FUSION; OXIDES; PROGNOSIS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SURVIVAL RATE; TRETINOIN;

EID: 0033254499     PISSN: 09255710     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (1)

1. Kakizuka A, Miller WH Jr, Umesono K, et al. Chromosomal translocation t(15;17) in human acute promyelocytic leukemia fuses RAR alpha with a novel putative transcription factor, PML. Cell 1991;66:663-74.